User contributions for Kashish Goel
Jump to navigation
Jump to search
28 May 2012
- 03:2303:23, 28 May 2012 diff hist +18 Deep vein thrombosis landmark trials in treatment /* EINSTEIN Study{{cite journal |author=Bauersachs R, Berkowitz SD, Brenner B, et al. |title=Oral rivaroxaban for symptomatic venous thromboembolism |journal=N. Engl. J. Med. |volume=363 |issue=26 |pages=2499–510 |year=2010 |month=December |pmid...
- 03:2203:22, 28 May 2012 diff hist +1,634 Deep vein thrombosis landmark trials in treatment →Rivoraxaban
- 02:0902:09, 28 May 2012 diff hist +2,822 N FDA Adverse Events Created page with "{{CMG}}; '''Associate Editor-In-Chief''': Kashish Goel,M.D. ==FDA definition of Adverse Event== {{cquote| '''What is a Serious Adverse Event?''' '''A..." current
- 02:0602:06, 28 May 2012 diff hist +322 Deep vein thrombosis landmark trials in treatment No edit summary
- 01:5601:56, 28 May 2012 diff hist +331 Deep vein thrombosis landmark trials in treatment →RE-COVER Study
- 01:5301:53, 28 May 2012 diff hist +907 Deep vein thrombosis landmark trials in treatment →Dabigatran
27 May 2012
- 20:3620:36, 27 May 2012 diff hist +42 Deep vein thrombosis landmark trials in treatment →Newer anticoagulants
- 20:3520:35, 27 May 2012 diff hist +1,414 Deep vein thrombosis landmark trials in treatment →Use of IVC filters
- 20:2120:21, 27 May 2012 diff hist +1,296 Deep vein thrombosis landmark trials in treatment /* Catheter-directed thrombolysis{{cite journal |author=Enden T, Kløw NE, Sandvik L, et al. |title=Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting o...
- 20:0820:08, 27 May 2012 diff hist +1,238 Deep vein thrombosis landmark trials in treatment →Catheter-directed thrombolysis
- 19:5619:56, 27 May 2012 diff hist +86 Deep vein thrombosis landmark trials in treatment No edit summary
- 19:5519:55, 27 May 2012 diff hist +7 Deep vein thrombosis landmark trials in treatment →Landmark Clinical Trials
- 19:5319:53, 27 May 2012 diff hist +2 Deep vein thrombosis landmark trials in treatment /* Meta-analysis of Home versus inpatient treatment of DVT{{cite journal |author=Schraibman IG, Milne AA, Royle EM |title=Home versus in-patient treatment for deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD0030...
- 19:5319:53, 27 May 2012 diff hist +333 Deep vein thrombosis landmark trials in treatment No edit summary
- 19:5219:52, 27 May 2012 diff hist +345 Deep vein thrombosis landmark trials in treatment →Trials comparing Low-molecular-weight Heparin With intravenous unfractionated Heparin
- 19:5119:51, 27 May 2012 diff hist +373 Deep vein thrombosis landmark trials in treatment →Trials comparing Low-molecular-weight Heparin With subcutaneous unfractionated Heparin
- 19:4919:49, 27 May 2012 diff hist +762 Deep vein thrombosis landmark trials in treatment →Trials comparing Low-molecular-weight Heparin With subcutaneous unfractionated Heparin
- 19:4619:46, 27 May 2012 diff hist −2 Deep vein thrombosis landmark trials in treatment /* Meta-analysis of Home versus inpatient treatment of DVT{{cite journal |author=Schraibman IG, Milne AA, Royle EM |title=Home versus in-patient treatment for deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD0030...
- 19:4519:45, 27 May 2012 diff hist +1,664 Deep vein thrombosis landmark trials in treatment →Meta-analysis assessing LMWH dosing
- 19:3619:36, 27 May 2012 diff hist +801 Deep vein thrombosis landmark trials in treatment →Trials regarding the use of Fondaprinux